← feed

Is NCT03279302 results overdue?

Yes — results are overdue. Primary completion was 2017-12-18; the FDAAA-801 reporting deadline (2018-12-18) passed 2742 days ago and no results are posted on ClinicalTrials.gov.

Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects

NCT IDNCT03279302 ↗
SponsorZealand Pharma (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-12-18 (ACTUAL)
Reporting deadline2018-12-18 (completion + 365d)
Days overdue2742
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 9a29593603732c32… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03279302. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →